EXEisMED: Exercise Training on Health and Medical Costs of Metabolic Syndrome Individuals.

Sponsor
University of Castilla-La Mancha (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05120778
Collaborator
(none)
207
2
49

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if an exercise training intervention together with conventional medical treatment can decrease the annual healthcare cost in patients with metabolic syndrome.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: exercise training
  • Other: conventional medical treatment
N/A

Detailed Description

It is proposed a multicentral clinical trial with cluster randomization among research nodes located in towns of Castilla-La Mancha and Toledo neighborhoods (Spain). The aim is to compare the annual healthcare cost of patients receiving conventional medical treatment against patients receiving the same intervention plus exercise training for 16 weeks. Exercise training will be based on high-intensity interval training conducted on stationary bikes, and strength training using weight-bearing exercises. Each research node will be composed of the clinical center and the sports facilities available in the town/neighborhood. Research nodes will be randomized into two experimental interventions: i.) conventional medical treatment, and ii.) conventional medical treatment + exercise training. After verbal and written information about the study and related potential risks, all patients fulfilling inclusion criteria will be included after giving written informed consent. At baseline, and after 12 and 24 months, annual healthcare costs will be obtained from the volunteers' clinical records. In addition, at baseline, and after 4, 12, and 24 months, metabolic syndrome components prevalence, metabolic syndrome z-score, body composition, and cardiorespiratory fitness will be tested.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
207 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Cluster randomized clinical trialCluster randomized clinical trial
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Effectiveness of Exercise Training on Health and Medical Costs of Metabolic Syndrome Factors in the Adult Population.
Anticipated Study Start Date :
Dec 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: conventional medical treatment

Volunteers will maintain habitual medical treatment.

Other: conventional medical treatment
participants will maintain habitual medical treatment prescribed by primary care and specialized physicians from the public health service.

Experimental: exercise training + conventional medical treatment

Volunteers will maintain habitual medical treatment and will participate in a 16-week exercise training based on high-intensity interval training (stationary bikes), and strength training (weight-bearing exercises).

Behavioral: exercise training
as appear in arm description.

Other: conventional medical treatment
participants will maintain habitual medical treatment prescribed by primary care and specialized physicians from the public health service.

Outcome Measures

Primary Outcome Measures

  1. Change of Annual healthcare cost [Baseline, month 12 and 24]

    From unified medical records, all clinical and paraclinical interventions including pharmacological treatment, diagnostic or therapeutic procedures and primary care and specialized medical consultations will be included

Secondary Outcome Measures

  1. Cardiorespiratory fitness [Baseline, month 4,12, and 24.]

    Estimation of vo2max from a graded exercise test plus a verification test

  2. Body composition [Baseline, month 4,12, and 24.]

    Measurement of the mass of man body compartments (i.e., fat mass, fat free mass, and bone mass) by dual energy x-ray absorptiometry.

  3. Blood lipids profile [Baseline, month 4,12, and 24.]

    Serum concentrations (in mg per dL) of triglycerides, total colesterol, high density lipoprotein after 8-hour fasting

  4. Glycemia [Baseline, month 4,12, and 24.]

    Serum concentrations of glycemia (in mg per dL) after 8-hour fasting

  5. Blood pressure [Baseline, month 4,12, and 24.]

    Systolic and diastolic values of blood pressure measures obtained from the brachial artery after 15 min of supine rest.

  6. Central obesity [Baseline, month 4,12, and 24.]

    Measurement of waist circumference (cm) in a horizontal plane, midway between the inferior margin of the ribs and the superior border of the iliac crest.

Other Outcome Measures

  1. Compliance to Exercise volume prescription . [Month 4]

    From the exercise training sessions records (exercise time in minutes), measurement of volume prescription (Target time)

  2. compliance to Exercise intensity prescription. [Month 4]

    From the exercise training sessions records (heart rate in beats per minute), measurement of compliance to exercise intensity prescription (target HR).

  3. Daily physical activity [Month 4,12, and 24.]

    Measurement of daily steps using pedometers

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Fulfilling criteria for metabolic syndrome diagnosis.
Exclusion Criteria:
  • At baseline, engagement to an exercise training program for the last 6 months.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Castilla-La Mancha

Investigators

  • Principal Investigator: Ricardo Mora-Rodriguez, PhD, University of Castilla-La Mancha

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Castilla-La Mancha
ClinicalTrials.gov Identifier:
NCT05120778
Other Study ID Numbers:
  • 8211121078-121078-57-421
First Posted:
Nov 15, 2021
Last Update Posted:
Nov 15, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Castilla-La Mancha
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2021